NIPG:NASDAQNIP Group Inc. Analysis
Data as of 2026-04-20 - not real-time
$0.71
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical weakness dominates the near‑term outlook. The stock trades well below its 20‑day, 50‑day and 200‑day moving averages, and the RSI sits in the low‑forties, indicating limited upside momentum. While the MACD histogram shows a modest bullish flare, the overall trend remains bearish and the 30‑day volatility exceeds 60%, reflecting erratic price swings. Compounding the price pressure, Nasdaq issued a deficiency notice for failing to meet the minimum bid price requirement, raising the risk of delisting. Fundamentally, the company is in distress. Margins are deeply negative, cash flow is flat, and debt dwarfs equity with a debt‑to‑equity ratio above 16, while the price‑to‑book of 0.32 suggests a heavy discount to net assets. Despite a modest revenue growth rate, the lack of earnings and a massive historical drawdown underscore the precarious financial position.
Valuation appears cheap on a book basis, but the risk premium is extreme. The absence of dividends, high beta, and exposure to volatile Chinese esports markets amplify both market and geographic risks. Given the confluence of technical weakness, regulatory scrutiny from Nasdaq, and a fragile balance sheet, the stock is best approached with caution.
Valuation appears cheap on a book basis, but the risk premium is extreme. The absence of dividends, high beta, and exposure to volatile Chinese esports markets amplify both market and geographic risks. Given the confluence of technical weakness, regulatory scrutiny from Nasdaq, and a fragile balance sheet, the stock is best approached with caution.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Nasdaq deficiency notice and potential delisting
- Bearish technical positioning below key moving averages
- Extremely high short‑term price volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential for restructuring given low price‑to‑book
- Continued uncertainty in cash flow generation
- Elevated beta and sector volatility
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Deep discount to book value may attract value investors
- Persistent negative margins and high debt limit upside
- Geopolitical and regulatory exposure in China and UAE
Key Metrics & Analysis
Financial Health
Revenue Growth55.50%
Profit Margin-134.51%
ROE-77.23%
ROA-6.00%
Debt/Equity16.28
P/B Ratio0.3
Industry P/E19.3
Technical Analysis
TrendBearish
RSI41.4
Support$0.63
Resistance$0.82
MA 20$0.72
MA 50$0.80
MA 200$1.40
MACDBullish
VolumeStable
Fear & Greed Index86.77
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.38
Volatility68.12%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.